Study Highlights
- A DNA vaccine helped lower blood pressure for up to six months, reduced tissue damage to the heart and blood vessels associated with hypertension in rats.
- If future research shows the vaccine is a viable treatment option in humans, it could improve high blood pressure levels.
A vaccine may one day help lower blood pressure for up to six months, according to new research in the American Heart Association’s journal Hypertension.
The study in rats may eventually provide a novel alternative to treat high blood pressure in people, who would not need to take a pill everyday.
“The potential of a vaccine for hypertension offers an innovative treatment that could be very effective for the control of non-compliance which is one of the major problems in the management of hypertensive patients,” said Hironori Nakagami M.D., Ph.D., study co-author and professor at Osaka University in Japan.
Researchers have designed a DNA vaccine that targets angiotensin II ? a hormone that raises blood pressure by causing blood vessels to constrict. This narrowing can increase your blood pressure and force your heart to work harder.
In the study, researchers immunized hypertensive rats three times at two-week intervals with needleless injections. The vaccine not only lowered blood pressure for up to six months, but also reduced tissue damage to the heart and blood vessels associated with hypertension. There were no signs of damage to other organs such as the kidney or liver.
The DNA vaccine works similar to common ACE inhibitor blood pressure medications which help blood vessels relax and open up, which, in turn, lowers blood pressure. Other types of vaccines have been tested for hypertension (e.g. a peptide vaccine), but didn’t have lasting effects and some had undesirable side effects.
The ultimate goal of an anti-hypertensive vaccine is to achieve perfect blood pressure control by improving drug compliance through the vaccine. In addition, in the developing countries like Africa and south Asia, anti-hypertensive drugs such as ARB (angiotensin receptor blockade) are expensive. A DNA vaccine may provide cheaper and effective anti-hypertensive treatments in such countries, researchers said.
Read more: Future vaccine may help lower blood pressure long-term
The Latest on: DNA vaccine
[google_news title=”” keyword=”DNA vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: DNA vaccine
- Cancer vaccine trialled on UK patients in world first amid hope of cureon April 27, 2024 at 12:51 pm
The jab tells the immune system how to identify and kill cancer cells and phase-two trial of the trialfound it dramatically improved survival in melanoma patients ...
- Joel Embiid finally discovers he has the DNA of a champion. Down 2-1, can he lead the Sixers past the Knicks?on April 27, 2024 at 2:00 am
What pain? What fear? With the memory of his brother and the presence of his son to inspire him, The Process is taking the final steps toward real dominance.
- Applied DNA gets contract from HDT Bio for vaccine development under a ‘Project NextGen: Enabler’on April 27, 2024 at 12:30 am
Applied DNA Sciences, Inc. (Applied DNA), a leader in PCR-based DNA technologies, announced the award of a contract from HDT Bio for the purpose of rapid, next-generation vaccine development under a ...
- Can cancer vaccine with immunotherapy shrink liver tumor?on April 26, 2024 at 7:30 pm
According to a study published in the journal Nature Medicine, people with Hepatocellular Carcinoma treated with immunotherapy and a personalized anti-tumor vaccine were twice as likely to experience ...
- UK Patients Testing World’s First Personalized mRNA Cancer Vaccine For Melanomaon April 26, 2024 at 1:26 pm
British patients are currently undergoing trials for a groundbreaking mRNA cancer vaccine tailored specifically for melanoma, with potential applications for lung, bladder, and kidney cancers as well.
- ‘Real hope’ for cancer cure as personal mRNA vaccine for melanoma trialledon April 26, 2024 at 3:07 am
Excitement among patients and researchers as custom-built jabs enter phase 3 trial ...
- Life-saving skin cancer vaccine trialled on British patients in world firston April 26, 2024 at 1:38 am
DNA sequencing and artificial intelligence are also involved ... And the side effects are said to be no worse than those of a flu vaccine. Professor Lawrence Young, of the University of Warwick, said: ...
- NHS trials first personal skin cancer jab that can halve risk of deathon April 25, 2024 at 11:00 pm
The world’s first personalised vaccine for skin cancer is to be offered to British patients as part of a “cordon bleu” treatment plan.
- Cancer cure hope as UK patients trial world’s first personalised mRNA vaccine for melanomaon April 25, 2024 at 10:32 pm
The world’s first personalised mRNA cancer jab for melanoma – which also has the potential to stop lung, bladder and kidney cancer – is being tested in British patients. The “gamechanger” jab, which ...
- Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Programon April 25, 2024 at 5:24 am
Under the terms of the contract, Applied DNA will supply Linea™ DNA IVT templates to HDT Bio for use in conjunction with its LION™ formulated repRNA (self-replicating RNA) vaccination platform. The ...
via Bing News